Yapeng Su

632 posts

Yapeng Su banner
Yapeng Su

Yapeng Su

@SuYapeng

K99-Damon Runyon Fellow @FredHutch, trainee of @labheath, David Baltimore, and Leroy Hood @Caltech & @isbsci. Systems Biology, Immunology, Cancer, Engineering

Fred Hutch Katılım Kasım 2019
528 Takip Edilen550 Takipçiler
Jerzy Szablowski
Jerzy Szablowski@JerzySzablowski·
Tenure. Deeply grateful to the students, postdocs, mentors, collaborators, and colleagues who made this possible. The next chapter will expand the lab towards a couple of new directions. The first grant for one of them just went out this morning :).
Jerzy Szablowski tweet media
English
19
4
150
11.9K
Lingyan Shi
Lingyan Shi@StimulatedRaman·
I am incredibly proud to share that my postdoc Yajuan has accepted a position as Tenure-Track Assistant Professor at Yale University. Please join me in congratulating her on this achievement! Many thanks to our colleagues, collaborators, friends, and group members.
Lingyan Shi tweet media
English
17
6
197
15.1K
Claire Bedbrook
Claire Bedbrook@clairebedbrook·
Aging may feel gradual… but what if it’s not? In our paper out today, we tracked fish continuously from puberty until death. This gave us a unique view of how aging unfolds across the adult lifespan. 🧵
English
22
148
558
71.3K
Shivani Srivastava
Shivani Srivastava@sriv4000·
Excited to share our lab’s latest work in @SciImmunology, examining how CAR-T cells bypass the niches that normally support stem-like subsets in vivo and how this influences their sensitivity to checkpoint blockade.
Fred Hutch Cancer Center@fredhutch

Published today in @SciImmunology: @sriv4000 and team find a new way to give #CARTcells their own portable pit crew, allowing them to rejuvenate on the go and transforms them into a type of T cell that can support long-term immune responses against tumors. bit.ly/3NiSged

English
2
2
6
1.9K
Jerzy Szablowski
Jerzy Szablowski@JerzySzablowski·
I am thrilled to be a part of this cohort and learning how to scale-up bold ideas from some of the most experienced innovators ARPA agencies and private sector. I will work to establish a new type of drug discovery pipeline that could target currently unsolvable disorders.
Renaissance Philanthropy@RenPhilanthropy

Meet the 14 exceptional scientists and innovators who will define the next decade of breakthrough innovation as the @coeff_giving x Big if True Science Accelerator Americas cohort. Here's what they're building: 🧵 1/15

English
1
5
30
4.7K
Yapeng Su retweetledi
Zihai Li, MD, PhD
Zihai Li, MD, PhD@Zihai·
This @Nature study (rdcu.be/eY5hC) shows that loss of the ubiquitin ligase KLHL6 in Tex cells prevents TOX degradation, stabilizing exhaustion and mitochondrial dysfunction. Another case linking proteostasis to T cell exhaustion. Congrats to @HutchGreenberg, Guideng Li.
Zihai Li, MD, PhD tweet media
English
1
8
85
7.8K
Yapeng Su retweetledi
nature
nature@Nature·
Nature research paper: The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction go.nature.com/457rivW
English
2
19
85
51.8K
Yapeng Su
Yapeng Su@SuYapeng·
📌 Take-home message: Targeting ubiquitin-mediated proteostasis can coordinate cell state and metabolism in T cells. KLHL6 is a multifunctional, clinically actionable target for next-gen immunotherapy.
English
1
0
0
110
Yapeng Su
Yapeng Su@SuYapeng·
🚨 Excited to share our collaborative work in @Nature ! 🚨 We identify KLHL6, an E3 ubiquitin ligase, as a key regulator that protects CD8⁺ T cells from both exhaustion and mitochondrial dysfunction — two major barriers in cancer immunotherapy. nature.com/articles/s4158…🧵👇
English
1
5
27
1.5K